Preliminary pharmacokinetics of 2‘,3’-dideoxycytidine in neonatal goats
Authors:
- 1 September 1989
- journal article
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 12 (3) , 334-339
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Broad spectrum antiretroviral activity of 2',3'-dideoxynucleosides.Proceedings of the National Academy of Sciences, 1987
- Strategies for antiviral therapy in AIDSNature, 1987
- Initial studies on the cellular pharmacology of 2′,3′-dideoxycytidine, an inhibitor of HTLV-III infectivityBiochemical Pharmacology, 1986
- Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.Proceedings of the National Academy of Sciences, 1986
- The Prospects for and Pathways toward a Vaccine for AIDSNew England Journal of Medicine, 1985
- Nucleotide sequence evidence for relationship of AIDS retrovirus to lentivirusesNature, 1985
- Estimation of Variance for Harmonic Mean Half-LivesJournal of Pharmaceutical Sciences, 1985
- Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1982
- Inhibition by 2′,3′-dideoxythymidine of retroviral infection of mouse and human cellsCancer Letters, 1980
- Maturational Changes in Glomerular Perfusion Rate and Glomerular Filtration Rate in LambsPediatric Research, 1974